Source: Benzinga

Ocular: Ocular Therapeutix to Participate in Two Investor Conferences in April

BEDFORD, Mass., March 31, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), a biopharmaceutical company committed to redefining the retina experience, today announced that the Company will participate in two investor conferences in April:24th Annual Needham Virtual Healthcare ConferencePresentation Date: Monday, April 7, 2025Presentation Time: 3:00 PM ETPresenter: Pravin U. Dugel, MD, Executive Chairman, President and CEOLocation: VirtualPiper Sandler Spring Biopharma SymposiumDate: Thursday, April 17, 2025Ocular Therapeutix to host investor one-on-one meetingsFull story available on Benzinga.com

Read full article »
Annual Revenue
$25-100M
Employees
250-500
Pravin U. Dugel's photo - Chairman & CEO of Ocular

Chairman & CEO

Pravin U. Dugel

CEO Approval Rating

83/100

Read more